Table 2: Antioxidant therapy in patients with vaginitis.
Samples |
Antioxidants |
Results |
References |
100 female patients with nonspecific vaginitis |
Vitamin C therapy (250 mg/day/one week) |
↓vaginal MDA; ↓vaginal H2O2; ↓mucosa epithelial cell apoptosis; ↓DNA damage ofmucosa epithelial cells; ↓caspase 3 expression; ⇑Bcl2; ↓Bax; ↓cytochrome C in mucosa epithelial cells |
[47] |
|
|
|
|
180 patients with bacterial vaginosis |
Berberine (as posterior vaginal fornix at 0.3 g/daily for 10 days) |
⇑SOD; ⇑CAT; ↓H2O2; ↓caspase-3, ↓cytochrome C, ↓capase-12; ↓Bax; ⇑Bcl-2; ↓Bax/Bcl-2 ratio in vaginal discharge |
[54] |
|
|
|
|
35 women with vaginal dryness |
Vitamins A, C and E; hyaluronic acid; collagen; glucosamine sulfate; chondroitin sulfate; alpha-lipoic acid; methylsulfonylmethane
|
⇑Vaginal Health Index; ⇑Female Sexual Function ↓Index; oxidative stress |
[55] |
100 women with non-specific vaginal dryness |
Vitamin C vaginal tablets (250 mg) once a day for a total of 20 days |
⇑Bacteria disappeared; ↓Vaginal pH; ↓clue cells; ⇑lactobacilli reappeared; ⇑vaginitis improvement |
[56] |